BiotechTube
Home/CARGO Therapeutics/Brett Hall, Ph.D.
BH

Brett Hall, Ph.D.

Chief Scientific Officer, Co-Founder

CARGO Therapeutics

Therapeutic Areas

OncologyHematology

CARGO Therapeutics Pipeline

DrugIndicationPhase
CRG-022Large B-cell lymphoma (LBCL) relapsed/refractory after CD19 CAR TPhase 2
CRG-023Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (NHL)Preclinical

Leadership Team at CARGO Therapeutics

GC
Gina Chapman
Interim Chief Executive Officer, Board Member
SA
Sunil Agarwal, M.D.
Chief Medical Officer
JR
John R. Desjarlais, Ph.D.
Chief Technology Officer
SJ
Steven J. Gannon
Chief Financial Officer
View full CARGO Therapeutics profile